The largest database of trusted experimental protocols

410 protocols using jmp pro 16

1

Clinicopathologic and Genomic Analyses of Lung Adenocarcinoma Subtypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Differences among groups in clinicopathologic variables were analyzed with Fisher’s exact test with statistical software (JMP Pro 16.1 software package for Windows; SAS, Tokyo, Japan). Differences in age and tumor size distributions were evaluated with Mann–Whitney’s U test in JMP Pro 16.1.
Differences in SCNA number, including gain, LOH and CN-LOH were evaluated with Mann–Whitney’s U test in JMP Pro16.1 (SAS, Tokyo, Japan). Differences in SCNAs between isolated cribriform-type and well-formed gland-type adenocarcinomas were analyzed with Fisher’s exact test. A P value <0.05 was considered significant. P values were adjusted with the Benjamini–Hochberg false discovery rate (FDR) for multiple comparisons.
Differences in mRNA expression levels between cribriform-type and well-formed gland-type adenocarcinomas for isolated cancer and normal glands were analyzed with the interaction analysis methods of Transcriptome Analysis Console 4.0.2 (Thermo Fisher Scientific, MA) (FDR-P value <0.05 and Δ Fold change ≥ absolute value 2).
+ Open protocol
+ Expand
2

Clinicopathological and Genomic Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Differences among groups in clinicopathological variables were analysed using Fisher's exact test with statistical software (JMP Pro 16.1 software package for Windows; SAS, Tokyo, Japan). Differences in age and tumour size distributions were evaluated using Mann–Whitney U tests in JMP Pro 16.1 (SAS).
Differences in SCNA numbers, including gains, LOH, and CN‐LOH, were evaluated using the Kruskal–Wallis test in JMP Pro 16.1 (SAS). Differences in SCNAs among IMNs, LGDs, HGDs, and IMCs were analysed using Fisher's exact tests. Results with p values less than 0.05 were considered significant. p values were adjusted with the Benjamini–Hochberg false discovery rate (FDR) for multiple comparisons.
Differences in mRNA expression levels between subgroups 1 and 2 or among LGDs, HGDs, and IMCs were analysed using limma v3.54.1 via R v4.2.2 (FDR p value <0.05 and logFold change ≥|1|).
+ Open protocol
+ Expand
3

Visualizing Metabolic Flux Patterns

Check if the same lab product or an alternative is used in the 5 most similar protocols
Principal component analysis (PCA) was performed on mapped predicted intracellular fluxes for each model using JMP 16 pro (SAS Institute Inc.). Visualizations and analysis were performed using Excel and JMP 16 pro (SAS Institute Inc.). Flux diagram maps were created using Escher (Rowe et al., 2018 (link)).
+ Open protocol
+ Expand
4

Dietary Potassium Attenuates Sodium Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Our primary outcome was brachial artery FMD measured on Day 10 of each condition. Secondary outcomes included TSI reperfusion slope and TSI AUC acquired from the NIRS‐VOT. An a priori power analysis determined that a sample size of 21 participants provided 95% power to detect a difference in FMD of at least 1% (effect size 0.83) at the end of the two arms using a paired samples t‐test with an alpha of 0.05 (G* Power). This difference in FMD was based on our results demonstrating that dietary potassium attenuated the effect of sodium (Smiljanec et al., 2020 (link)). An improvement of 1% in FMD is clinically significant based on a recent meta‐analysis that found a 1% improvement in FMD was associated with a decrease of 8%–10% in overall CVD risk over 4 years (Ras et al., 2013 (link)). Comparisons between the two conditions for all variables were assessed using paired t‐tests. Although not powered to detect sex differences, an exploratory analysis was conducted to examine potential differences between men and women in their response to the two conditions. Therefore, the difference score was calculated for the primary outcomes for men and women and was compared using an unpaired t‐test. Data were assessed for normality prior to analysis. JMP Pro 16.0.0 (SAS, Cary, NC) was used to carry out the analysis. Significance was set at p < 0.05.
+ Open protocol
+ Expand
5

Comparative Analysis of Molecular Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
All data are presented as the median (range). The Wilcoxon rank-sum test was used to compare the variables between the two groups. Fisher's exact test was performed for categorical variables. Statistical significance was defined as p < 0.05. All statistical analyses were performed using JMP Pro 16.0.0® (SAS Institute Inc., Cary, NC, USA).
+ Open protocol
+ Expand
6

Diagnostic Accuracy of Occult Hepatocellular Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data were expressed as median values (range) as appropriate. Comparisons between the groups were done using the Wilcoxon signed-rank test. Receiver operating characteristic curves were constructed, and the areas under the curves were compared to test the ability to diagnose occult HCC. Optimal cut-off values for the different scales were determined the Youden’s index, which is the value that maximizes the sum of the sensitivity and specificity. Statistical significance was set at p <0.05. Statistical analyses were performed using JMP Pro 16.0.0 software (SAS Institute Inc., Cary, NC, USA).
+ Open protocol
+ Expand
7

Analyzing Progression-Free Survival

Check if the same lab product or an alternative is used in the 5 most similar protocols
The probability of PFS was calculated according to the Kaplan–Meier method, with differences assessed using the log‐rank test. The 95% confidence interval (CI) for the median was computed. The significance level was set at 0.05. All statistical tests are two‐sided. All statistical analyses were conducted using SPSS version 19 (IBM SPSS Statistics, IBM). As for experiments using cell lines and animal models, overall comparisons were performed by ANOVA, and pairwise comparisons were conducted using Tukey's test. Significance was determined by p < 0.01. Most calculations were performed using JMP Pro 16.0.0 (SAS Institute).
+ Open protocol
+ Expand
8

Recurrence-Free Survival and Overall Survival Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RFS was calculated from the date of surgery until the date of the first recurrence. Overall survival (OS) was calculated from the date of surgery until the date of death. The censored was the last date of survival confirmation. These were calculated for various subsets of prognostic factors using the Kaplan–Meier method and log-rank test. The χ2 test was used to estimate sensitivity. Two-sided p values of < 0.05 were considered as statistically significant. Statistical analyses were performed using JMP® Pro 16.0.0 (SAS Institute Inc., Cary, NC, USA).
+ Open protocol
+ Expand
9

Statistical Analysis of Experimental Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
JMP Pro 16.0.0 (SAS Institute, Cary, North Carolina) was used to perform the statistical analysis. Factorial analysis and standard least squares regression models were performed and the significance among treatments within a trial were determined at P ≤ 0.05. since there were significant interactions between the trials for many variables that the data within each trial were analyzed separately. Tukey’s HSD or student’s t tests were used to differentiate means in statistically significant results. A multivariate correlation analysis was also performed to determine relationships between analyzed factors.
+ Open protocol
+ Expand
10

Propensity Score Matching for SGLT2 Inhibitor Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
To minimize bias for potential confounders, SGLT2 inhibitor-treated and non-treated groups were selected using propensity scores calculated by logistic regression using the baseline characteristics described above. A greedy nearest neighbor matching algorithm with a caliper width equal to 0.2 of the logit standard deviation of the propensity score was used to create matched pairs between the SGLT2 inhibitor-treated and non-treated groups. The equilibrium of the matching model was assessed using standardized differences in the means of each covariate. A threshold of 0.20 was used to identify imbalance in the baseline covariates. Matching model refinements were repeated until balance was achieved.
Data are presented as mean ± standard deviation, and Student's t-test was used to compare means between the two groups. The significance level for each test was defined as p < 0.05. All analyses were conducted using JMP software (JMP Pro 16.0.0; SAS Institute, Japan). The normality of distribution was checked using the Shapiro–Wilk normality test, followed by comparison with an unpaired Student's t-test.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!